Where would you like to sign in?

DiaMedica to Present at the 2016 BFC Global Healthcare Business Development and Investment Conference

MINNEAPOLIS, MINNESOTA--(Marketwired - April 11, 2016) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), today announced that the Company will be presenting at the 2016 BFC Global Healthcare Business Development and Investment Conference taking place April 13th to 15th at the Marriott Hotel City Centre in Shanghai, China.

Rick Pauls, President and CEO, is scheduled to present on Thursday, April 14th at 11am local time. Management will also be available for one-on-one meetings as they meet with the Chinese investment community and pharmaceutical companies throughout the week.

About the 2016 BFC Global Healthcare Business Development and Investment Conference

The BFC Global Healthcare Business Development and Investment Conference is held April 13-15 at the Marriott Hotel City Centre in Shanghai, China. Many of the leading private and public healthcare companies across the biopharmaceutical, medical device, and healthcare sectors in China will participate in this high profile event. This global gathering provides opportunities for investors and executives to address the near and long-term business development and investment opportunities regarding the healthcare industry as well as the mechanisms driving the healthcare sector in China and internationally. The Conference will include corporate presentations, Q&A breakout sessions, and keynote speakers; investor one-on-one and small group meetings; and networking opportunities.

About DiaMedica

DiaMedica is a publicly traded clinical stage biopharmaceutical company focused on developing novel treatments for stroke and other vascular diseases. DiaMedica's common shares are listed on the TSX Venture Exchange under the trading symbol "DMA" and on the OTCQB under the trading symbol "DMCAF".

FORWARD-LOOKING STATEMENTS

The statements made in this press release that are not historical facts contain forward-looking information that involves risk and uncertainties. All statements, other than statements of historical facts, which address DiaMedica's expectations, should be considered forward-looking statements. Such statements are based on management's exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "may", "will", "anticipate", "believe", "estimate", "expect", "intend" and words of similar import, are intended to identify any forward-looking statements. You should not place undue reliance on these forward-looking statements. Forward looking statements in this news release include, but are not limited to, the Company's objectives, goals, future plans and statements regarding the use of proceeds from the private placement. Factors that could cause actual results to differ materially from such forward-looking information described in detail in the DiaMedica's filings with the Canadian securities regulators, all of which are available on SEDAR (www.sedar.com). Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results could differ materially from those anticipated in these forward-looking statements. DiaMedica undertakes no obligation, and does not intend, to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of any unanticipated events, unless required by law. Although management believes that expectations are based on reasonable assumptions, no assurance can be given that these expectations will materialize.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the contents of this press release.